Search

Your search keyword '"Thorens, Bernard"' showing total 569 results

Search Constraints

Start Over You searched for: Author "Thorens, Bernard" Remove constraint Author: "Thorens, Bernard" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
569 results on '"Thorens, Bernard"'

Search Results

2. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

6. The glucose transporter 2 regulates CD8+ T cell function via environment sensing

8. Identification of biomarkers for glycaemic deterioration in type 2 diabetes

10. Oral metformin transiently lowers post-prandial glucose response by reducing the apical expression of sodium-glucose co-transporter 1 in enterocytes

15. Building the Glucagon-Like Peptide-1 Receptor Brick by Brick: Revisiting a 1993 Diabetes Classic by Thorens et al.

19. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study

20. Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes

25. Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes

29. Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion

31. Fostering improved human islet research: a European perspective

33. Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets

34. Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes

38. Hyperglycemia increases SCO-spondin and Wnt5a secretion into the cerebrospinal fluid to regulate ependymal cell beating and glucose sensing.

39. Tmem117 in AVP neurons regulates the counterregulatory response to hypoglycemia.

43. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation

47. SAT-231 GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study

49. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment

Catalog

Books, media, physical & digital resources